Full View

Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

K Boesen, AS Paludan-Müller… - Cochrane Database …, 2022 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a psychiatric diagnosis
increasingly used in adults. The recommended first‐line pharmacological treatment is …
被引用次数：28 相关文章
[PDF] researchgate.net

[PDF][PDF] Extended-release methylphenidate for attention deficit hy-peractivity disorder (ADHD) in adults

K Boesen, PB Danborg, PC Gøtzsche… - status and date: New …, 2017 - researchgate.net
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
(Protocol) Page 1 Cochrane Database of Systematic Reviews Extended-release …

Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

K Boesen, AS Paludan-Müller… - The Cochrane …, 2022 - europepmc.org
Background Attention deficit hyperactivity disorder (ADHD) is a psychiatric diagnosis
increasingly used in adults. The recommended first-line pharmacological treatment is central …

Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

K Boesen, AS Paludan-Müller… - The Cochrane …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Attention deficit hyperactivity disorder (ADHD) is a psychiatric diagnosis
increasingly used in adults. The recommended first-line pharmacological treatment is central …

[引用][C] Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults (Protocol)

K Boesen, PB Danborg, PC Gøtzsche… - … Database Syst Rev., 2017 - research.regionh.dk
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
(Protocol) — The Capital Region of Denmark's Research Portal Skip to main navigation Skip to …

Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

K Boesen, AS Paludan-Müller… - Cochrane …, 2022 - portal.findresearcher.sdu.dk
Background: Attention deficit hyperactivity disorder (ADHD) is a psychiatric diagnosis
increasingly used in adults. The recommended first-line pharmacological treatment is central …

[引用][C] Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

Cochrane Developmental, Psychosocial … - Cochrane Database …, 1996 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a psychiatric diagnosis
increasingly used in adults. The recommended first‐line pharmacological treatment is …
[HTML] nih.gov

[HTML][HTML] Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

K Boesen, AS Paludan-Müller… - The Cochrane …, 2022 - ncbi.nlm.nih.gov
Background Attention deficit hyperactivity disorder (ADHD) is a psychiatric diagnosis
increasingly used in adults. The recommended first‐line pharmacological treatment is …

Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

K Boesen, P Danborg, P Gøtzsche… - The Cochrane Database …, 2017 - europepmc.org
Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
[HTML] nih.gov

[HTML][HTML] Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults

K Boesen, PB Danborg, PC Gøtzsche… - … Cochrane Database of …, 2017 - ncbi.nlm.nih.gov
Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …